Founded in 2000, Benchmark has been built through organic innovation and strategic acquisitions. In 2013, we listed on the AIM market of the London Stock Exchange.
Launched Benchmark Genetics in Chile
Becomes one of only 5 companies to feature in the London Stock Exchange Group’s ‘1000 Companies to Inspire Britain’ report for 5th Consecutive year.
Reached 1,000 employees
Signed a long-term agreement with SalMar, one of the world’s leading salmon producers, to provide genetics, health and knowledge services to the company.
Added shrimp to our aquaculture breeding business through the acquisition of a South American shrimp breeding programme.
Acquired the number 1 advanced aquaculture nutrition provider, INVE Aquaculture.
Added Norwegian, Akvaforsk Genetics Center AS, and tilapia breeding company, Spring Genetics to strengthen our genetics offering.
Acquired TomAlgae, a pioneer in the development and production of freeze dried microalgae for use as feed for shrimp and fish.
Acquired thought leadership vehicle, Improve International, a veterinary training business
Completed an acquisition of the second and third-ranked international salmon breeding companies, SalmoBreed and StofnFiskur.
Floated on the London Stock Exchange AIM market.
Acquired leading aquaculture research facility in Scotland to advance the development of our product pipeline.
Acquired Novartis’s vaccine manufacturing plant in Braintree, UK.
1st move into aquaculture with the purchase of aquaculture health business, Fish Vet Group (FVG).
Acquired thought leadership and education provider, 5m Publishing
Benchmark is established on an Oxfordshire University farm to drive improvements in the food supply chain.